PMID- 14554207 OWN - NLM STAT- MEDLINE DCOM- 20031118 LR - 20211008 IS - 0736-0266 (Print) IS - 0736-0266 (Linking) VI - 21 IP - 6 DP - 2003 Nov TI - cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. PG - 970-5 AB - The aetiology and pathogenesis of chronic painful Achilles tendinosis are unknown. This investigation aimed to use cDNA arrays and real-time quantitative polymerase chain reaction (real-time PCR) technique to study tendinosis and control tissue samples. Five patients (females mean age 57.1+/-4.3 (years+/-SD)) with chronic painful Achilles tendinosis were included. From all patients, one biopsy was taken from the area with tendinosis and one from a clinically normal area (control) of the tendon. The tissue samples were immediately immersed in RNAlater and frozen at -80 degrees C until RNA extraction. Portions of pooled RNA from control and tendinosis sites, respectively, were transcribed to cDNA, radioactively labelled (32P), hybridized to cDNA expression arrays, and exposed to phosphoimager screens over night. Expressions of specific genes, shown to be regulated in the cDNA array analysis, were analyzed in the individual samples using real-time PCR. cDNA arrays showed that gene expressions for matrix-metalloproteinase-2 (MMP-2), fibronectin subunit B (FNRB), vascular endothelial growth factor (VEGF), and mitogen-activated protein kinase p38 (MAPKp38) were up-regulated, while matrix-metalloproteinase-3 (MMP-3) and decorin were down-regulated, in tendinosis tissue compared with control tissue. Using real-time PCR, 4/5 and 3/5 patients showed up-regulation of MMP-2 and FNRB mRNA, respectively. For decorin, VEGF, and MAPKp38, real-time PCR revealed a great variability among patients. Interestingly, the mRNAs for several cytokines and cytokine receptors were not regulated, indicating the absence of an inflammatory process in chronic painful Achilles tendinosis. In conclusion, cDNA-arrays and real-time PCR can be used to study differences in gene expression levels between tendinosis and control tendon tissue. FAU - Alfredson, Hakan AU - Alfredson H AD - Department of Surgical and Perioperative Science, Sports Medicine Unit, University of Umea, S-901 87 Umea, Sweden. hakan.alfredson@idrott.umu.se FAU - Lorentzon, Mattias AU - Lorentzon M FAU - Backman, Stina AU - Backman S FAU - Backman, Assar AU - Backman A FAU - Lerner, Ulf H AU - Lerner UH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Orthop Res JT - Journal of orthopaedic research : official publication of the Orthopaedic Research Society JID - 8404726 RN - 0 (DCN protein, human) RN - 0 (Decorin) RN - 0 (Extracellular Matrix Proteins) RN - 0 (Fibronectins) RN - 0 (Proteoglycans) RN - 0 (RNA, Messenger) RN - 0 (Vascular Endothelial Growth Factor A) RN - 9007-49-2 (DNA) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.4.24.- (Matrix Metalloproteinases) SB - IM MH - Achilles Tendon/*metabolism MH - DNA/analysis MH - Decorin MH - Extracellular Matrix Proteins MH - Female MH - Fibronectins/genetics/metabolism MH - *Gene Expression Profiling MH - Gene Expression Regulation MH - Humans MH - Matrix Metalloproteinases/genetics/metabolism MH - Middle Aged MH - Mitogen-Activated Protein Kinases/genetics/metabolism MH - Oligonucleotide Array Sequence Analysis/*methods MH - Proteoglycans/genetics/metabolism MH - RNA, Messenger/genetics MH - *Reverse Transcriptase Polymerase Chain Reaction MH - Tendinopathy/genetics/*metabolism/pathology MH - Vascular Endothelial Growth Factor A/genetics/metabolism MH - p38 Mitogen-Activated Protein Kinases EDAT- 2003/10/14 05:00 MHDA- 2003/12/03 05:00 CRDT- 2003/10/14 05:00 PHST- 2003/10/14 05:00 [pubmed] PHST- 2003/12/03 05:00 [medline] PHST- 2003/10/14 05:00 [entrez] AID - S0736026603001074 [pii] AID - 10.1016/S0736-0266(03)00107-4 [doi] PST - ppublish SO - J Orthop Res. 2003 Nov;21(6):970-5. doi: 10.1016/S0736-0266(03)00107-4.